| Primary |
| Depression |
56.3% |
| Drug Use For Unknown Indication |
29.0% |
| Product Used For Unknown Indication |
3.6% |
| Anxiety |
3.0% |
| Bipolar Disorder |
1.5% |
| Major Depression |
1.5% |
| Attention Deficit/hyperactivity Disorder |
0.8% |
| Seasonal Affective Disorder |
0.6% |
| Smoking Cessation Therapy |
0.6% |
| Migraine |
0.4% |
| Sleep Disorder |
0.4% |
| Insomnia |
0.3% |
| Asthma |
0.3% |
| Panic Attack |
0.3% |
| Stress |
0.3% |
| Contraception |
0.2% |
| Hypertension |
0.2% |
| Hypothyroidism |
0.2% |
| Obsessive-compulsive Disorder |
0.2% |
| Restless Legs Syndrome |
0.2% |
|
| Drug Ineffective |
9.8% |
| Tinnitus |
8.5% |
| Tremor |
7.5% |
| Urticaria |
6.3% |
| Insomnia |
6.1% |
| Rash |
5.9% |
| Nausea |
5.8% |
| Pharmaceutical Product Complaint |
5.7% |
| Alopecia |
5.0% |
| Weight Decreased |
4.9% |
| Weight Increased |
4.7% |
| Convulsion |
4.6% |
| Headache |
4.0% |
| Overdose |
4.0% |
| Suicidal Ideation |
3.9% |
| Vomiting |
3.8% |
| Vision Blurred |
3.0% |
| Therapeutic Response Unexpected |
2.3% |
| Depression |
2.2% |
| Dizziness |
2.1% |
|
| Secondary |
| Depression |
43.4% |
| Drug Use For Unknown Indication |
14.8% |
| Product Used For Unknown Indication |
8.7% |
| Bipolar Disorder |
5.1% |
| Anxiety |
4.0% |
| Dyspepsia |
2.7% |
| Hypertension |
2.3% |
| Affective Disorder |
2.1% |
| Insomnia |
2.1% |
| Major Depression |
2.0% |
| Foetal Exposure During Pregnancy |
1.8% |
| Pain |
1.6% |
| Migraine |
1.5% |
| Seasonal Affective Disorder |
1.4% |
| Generalised Anxiety Disorder |
1.3% |
| Epilepsy |
1.1% |
| Hysterectomy |
1.1% |
| Asthma |
1.0% |
| Bronchitis |
1.0% |
| Restless Legs Syndrome |
1.0% |
|
| Therapeutic Response Unexpected With Drug Substitution |
14.2% |
| Weight Increased |
12.7% |
| Tremor |
9.5% |
| Suicidal Ideation |
6.2% |
| Drug Ineffective |
5.8% |
| Somnolence |
4.7% |
| Weight Decreased |
4.0% |
| Death |
3.6% |
| Nausea |
3.6% |
| Pharmaceutical Product Complaint |
3.6% |
| Rash |
3.6% |
| Swelling Face |
3.6% |
| Tinnitus |
3.6% |
| Vomiting |
3.6% |
| Vision Blurred |
3.3% |
| Depression |
2.9% |
| Feeling Abnormal |
2.9% |
| Grand Mal Convulsion |
2.9% |
| Product Quality Issue |
2.9% |
| Headache |
2.5% |
|
| Concomitant |
| Depression |
19.4% |
| Product Used For Unknown Indication |
18.2% |
| Drug Use For Unknown Indication |
8.0% |
| Anxiety |
6.8% |
| Bipolar Disorder |
6.4% |
| Pain |
6.1% |
| Insomnia |
4.2% |
| Multiple Sclerosis |
3.7% |
| Hypertension |
3.6% |
| Sleep Disorder |
3.2% |
| Restless Legs Syndrome |
2.7% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Rheumatoid Arthritis |
2.2% |
| Schizophrenia |
2.1% |
| Contraception |
2.0% |
| Back Pain |
1.9% |
| Migraine |
1.9% |
| Hepatitis C |
1.7% |
| Asthma |
1.6% |
| Fibromyalgia |
1.5% |
|
| Weight Increased |
13.8% |
| Type 2 Diabetes Mellitus |
11.2% |
| Weight Decreased |
9.9% |
| Vomiting |
9.5% |
| Drug Ineffective |
5.5% |
| Pulmonary Embolism |
5.1% |
| Rash |
5.0% |
| Pain |
4.7% |
| Urinary Tract Infection |
4.1% |
| Suicidal Ideation |
4.0% |
| Nausea |
3.5% |
| Vision Blurred |
3.5% |
| Headache |
3.1% |
| Tremor |
3.1% |
| Pancreatitis |
2.9% |
| Pneumonia |
2.5% |
| Oedema Peripheral |
2.2% |
| Somnolence |
2.2% |
| White Blood Cell Count Decreased |
2.1% |
| Deep Vein Thrombosis |
2.0% |
|
| Interacting |
| Anxiety |
33.3% |
| Depression |
33.3% |
| Nasopharyngitis |
33.3% |
|
| Toxicity To Various Agents |
50.0% |
| Vomiting |
50.0% |
|
